HealthcareServices

Orlistat Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 27, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the orlistat market from 2026–2035 with trusted insights from The Business Research Company

How is the Orlistat Market size predicted to change over the forecast window of 2026–2035?

The orlistat market has experienced robust expansion in recent times. Forecasts indicate it will expand from $3.2 billion in 2025 to $3.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. This historical growth is attributable to several factors, including the increasing prevalence of obesity and overweight individuals, enhanced clinical adoption of orlistat, expanded availability of over-the-counter (OTC) orlistat, a surge in health awareness initiatives regarding obesity, and the early embrace of orlistat in developed economies.

The orlistat market is set to experience significant expansion over the next few years, with projections indicating it will reach $4.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected growth during the forecast period is primarily driven by the increasing acceptance of orlistat in new markets, a rising preference for non-invasive treatments for obesity, its deeper integration into existing weight management programs, an uptick in healthcare initiatives focused on obesity prevention, and continuous technological progress in its formulation and delivery. Prominent trends anticipated within this forecast timeframe include the escalating adoption of orlistat as a therapeutic option for weight control, a growing demand for both prescription and over-the-counter orlistat products, an increased emphasis on combining orlistat with lifestyle modifications, a rising need for weight loss solutions that complement low-fat diets, and improved public awareness regarding obesity management and preventative health.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

Which Drivers Are Contributing To The Expansion Of The Orlistat Market?

The orlistat market is anticipated to expand due to rising obesity rates. Obesity is a medical state defined by an excessive buildup of body fat, which can detrimentally affect health. Its common measurement is a body mass index (BMI) of 30 or higher. The increase in obesity stems from elements like inadequate diet, insufficient physical activity, and inactive lifestyles. Orlistat aids in obesity management by blocking the absorption of dietary fats, thus assisting in weight reduction and sustaining weight loss. It is frequently prescribed in conjunction with a calorie-restricted diet and exercise for improved outcomes. For example, a 2024 report from the World Obesity Federation, a UK-based non-profit organization, indicated that by 2035, 79% of adults struggling with overweight and obesity will reside in Low- and Middle-Income Countries (LMICs). Additionally, 88% of children who are overweight and obese will be living in LMICs by 2035. Consequently, the escalating obesity rates are fueling the expansion of the orlistat market.

What Segment Categories Are Covered In The Orlistat Market?

The orlistat market covered in this report is segmented –

1) By Type: 120 Milligram (Mg), 60 Milligram (Mg)

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Weight-Reducing Aid, Other Applications

Subsegments:

1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat

2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat

Which Trends Are Expected To Influence The Orlistat Market In The Upcoming Years?

Leading companies operating within the orlistat market are developing innovative products, such as weight loss drugs, to enhance personal hygiene and comfort through advanced technology and design. A weight loss drug refers to a medication designed to help individuals reduce body weight by suppressing appetite, increasing metabolism, or blocking fat absorption. For instance, in November 2023, Eli Lilly and Company, a US-based pharmaceutical company, received US Food and Drug Administration (FDA) approval for Zepbound (tirzepatide) injection, a new weight loss drug. It is the first and only approved treatment that activates two incretin hormone receptors, GIP and GLP-1, addressing an underlying cause of excess weight. Zepbound is indicated for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI =30 kg/m²) or overweight (BMI =27 kg/m²) with at least one weight-related condition.

Which Key Market Players Are Investing In Expansion And Innovation Within The Orlistat Market?

Major companies operating in the orlistat market are Merck & Co. Inc., GlaxoSmithKline plc, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd., Aurobindo Pharma Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

Which Regions Are Projected To Dominate The Orlistat Market In The Coming Years?

North America was the largest region in the orlistat market in 2025. The regions covered in the orlistat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Orlistat Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

Browse Through More Reports Similar to the Global Orlistat Market 2026, By The Business Research Company

Auditing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/auditing-services-global-market-report

Oryzanol Market Report 2026

https://www.thebusinessresearchcompany.com/report/oryzanol-global-market-report

Orthobiologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795